Adicet Bio, Inc.
ACET- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001720580
No open-market purchases or sales by Adicet Bio, Inc. insiders were filed in the last 90 days; 56 institutions reported holding it in 13F filings for Q2 2026, worth $52.8M in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Adicet Bio, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Of which not filed for Q4 2023 | Q4 2023 | Change |
|---|---|---|---|---|
| Holders | 84 | 1 | 77 | −6 |
| Shares | 35.7M | 200.2K | 33.4M | −2.11M (−5.9%) |
| Value | $48.9M | $274.3K | $63.0M | +$14.5M (+29.8%) |
1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (8)
Institutions that held Adicet Bio, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Schonfeld Strategic Advisors LLC | 200,100 | $378.2K | 0.00% |
| Panagora Asset Management Inc | 51,746 | $97.8K | 0.00% |
| SEI Investments Co | 31,012 | $58.6K | 0.00% |
| Jane Street Group, LLC | 23,012 | $43.5K | 0.00% |
| Wexford Capital LP | 14,930 | $28.2K | 0.01% |
| Invesco Ltd. | 10,446 | $19.7K | 0.00% |
| GAMMA Investing LLC | 3,829 | $11.4K | 0.00% |
| Northwest Financial Advisors | 1,685 | $3.19K | 0.00% |
Sold out (14)
Institutions that held Adicet Bio, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| DAFNA Capital Management LLC | 797,054 | $1.09M |
| Jacobs Levy Equity Management, Inc | 333,593 | $457.0K |
| Marshall Wace, LLP | 152,508 | $208.9K |
| Acuitas Investments, LLC | 136,779 | $187.4K |
| AQR Capital Management LLC | 75,022 | $102.8K |
| Marquette Asset Management, LLC | 28,144 | $38.6K |
| American Century Companies Inc | 21,791 | $29.9K |
| Balyasny Asset Management LLC | 12,550 | $17.2K |
| Comerica Bank | 1,250 | $1.71K |
| China Universal Asset Management Co., Ltd. | 1,103 | $1.51K |
| Russell Investments Group, Ltd. | 701 | $960 |
| Nisa Investment Advisors, LLC | 88 | $121 |
| Signaturefd, LLC | 16 | $22 |
| Daiwa Securities Group Inc. | 117 | $0 |
Not filed for Q4 2023 yet (1)
Institutions that held Adicet Bio, Inc. at the end of Q3 2023 and haven't filed a 13F for Q4 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Decheng Capital Management III (Cayman), LLC | 200,201 | $274.3K |